Skip to main content

Table 1 Summarized characteristics of the patients

From: Retrospective analysis of the success and safety of Gold Micro Shunt Implantation in glaucoma

Agea Glaucoma Previous interventionsb Cup-disc ratio Baseline IOPc End IOPd Follow up months Next intervention Outcomee
70 Sec P-T1 0.95 57 (4) 24 (0) 5.8 T F(3)
70 POAG none 0.80 34 (3) 44 (1) 8.9 T F(1,3)
70 PEX P 1.00 40 (3) 39 (3) 1.4 T F(3)
60 POAG none 0.95 16 (3) 21 (4) 2.2 T F(3)
60 POAG none 1.00 34 (0) 32 (3) 5.8 T F(3)
80 POAG P 0.85 18 (1) 17 (3) 5.0 T F(3)
60 POAG none 1.00 34 (0) 30 (3) 5.3 T F(3)
70 POAG P 0.80 17 (0) 17 (3) 7.9 T F(1,3)
40 POAG none 0.40 32 (4) 33 (1) 1.6 T F(3)
80 CAG P-C2 1.00 36 (2) 28 (3) 5.9 T F(3)
30 POAG T3-C1 0.95 17 (3) 18 (4) 2.8 T F(3)
70 CAG P-I-C3 1.00 28 (5) 17 (3) 3.4 T F(3)
80 PEX T3 1.00 26 (1) 44 (1) 9.3 T F(1,3)
40 Pigment none 0.90 30 (2) 29 (1) 4.5 T F(3)
70 PEX none 0.95 30 (4) 42 (1) 18.0 T F(1,3)
80 CAG P-I 0.80 25 (4) 28 (4) 1.0 T F(3)
30 Sec P 0.95 28 (2) 25 (0) 37.1 T-GMS ex F(1,2,3)
50 POAG none 1.00 16 (1) 17 (1) 12.2 T-GMS ex F(1,3)
60 POAG P-A-T2 1.00 20 (3) 34 (0) 1.2 T-GMS ex F(3)
60 Sec P-T1 1.00 24 (2) 50 (1) 14.2 B F(1,3)
60 POAG P-A3-T2 1.00 20 (1) 21 (2) 9.0 B F(1,3)
80 PEX P-T1 0.95 43 (1) 32 (0) 1.3 B F(3)
60 Sec C1 0.60 40 (5) 46 (1) 0.5 Cryo F(3)
60 PEX TA 0.40 27 (2) 28 (1) 5.3 P-GMS ex F(2,3)
60 POAG none 0.75 15 (0) 14 (0) 18.5 GMS ex F(1,2,3)
60 POAG none 0.80 14 (1) 12 (0) 12.2 GMS ex F(1,2,3)
40 POAG none 0.85 17 (0) 18 (2) 21.6 None F(1)
50 POAG T1 1.00 12 (2) 19 (0) 6.7 None F(1)
50 POAG T1 0.95 26 (0) 26 (0) 41.3 None F(1)
40 Pigment B-T1 0.80 20 (2) 24 (2) 6.6 None F(1)
60 POAG P 0.85 28 (5) 14 (0) 46.1 None success
  1. aAge in years when implanted (rounded half to even for de-identification).
  2. bPrevious interventions with number of interventions.
  3. cBaseline IOP (mmHg) on the day before GMS+ implantation (sum of different active ingredients in IOP lowering therapy).
  4. dIOP at the end of the follow-up (mmHg) (sum of different active ingredients in IOP lowering therapy).
  5. eOutcome of GMS+ implant; F, failure (criteria met), for details see Methods.
  6. Abbreviations: Sec secondary glaucoma, P pseudophakic, T trabeculectomy with mitomycin C, I iridectomy, C cyclodestructive intervention, TA trabecular aspiration, A argon laser trabeculoplasty, B Baerveldt implantation, GMS ex GMS+ explantation, Cryo Cryotherapy.